Bd
Monthly
The FACSChorus software does not properly assign data access privileges for operating system user accounts. Rated low severity (CVSS 3.5), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
The FACSChorus software database can be accessed directly with the privileges of the currently logged-in user. Rated medium severity (CVSS 4.3), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
The FACSChorus software contains sensitive information stored in plaintext. Rated medium severity (CVSS 4.3), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
The FACSChorus workstation does not prevent physical access to its PCI express (PCIe) slots, which could allow a threat actor to insert a PCI card designed for memory capture. Rated low severity (CVSS 2.4), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
The Operating System hosting the FACSChorus application is configured to allow transmission of hashed user credentials upon user action without adequately validating the identity of the requested. Rated low severity (CVSS 3.8), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
There is no BIOS password on the FACSChorus workstation. Rated medium severity (CVSS 5.2), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
The FACSChorus workstation operating system does not restrict what devices can interact with its USB ports. Rated medium severity (CVSS 5.7), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
An insecure connection between Systems Manager and CQI Reporter application could expose infusion data to an attacker. Rated low severity (CVSS 3.5), this vulnerability is low attack complexity. No vendor patch available.
Alaris Systems Manager does not perform input validation during the Device Import Function. Rated medium severity (CVSS 6.9), this vulnerability is low attack complexity. No vendor patch available.
A malicious file could be uploaded into a System Manager User Import Function resulting in a hijacked session. Rated high severity (CVSS 8.2), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
A GRE dataset file within Systems Manager can be tampered with and distributed to PCUs. Rated medium severity (CVSS 6.7), this vulnerability is low attack complexity. No vendor patch available.
The data flowing between the PCU and its modules is insecure. Rated medium severity (CVSS 6.1), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
The configuration from the PCU can be modified without authentication using physical connection to the PCU. Rated medium severity (CVSS 6.8), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
The firmware update package for the wireless card is not properly signed and can be modified. Rated medium severity (CVSS 5.7), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
The BD BodyGuard™ infusion pumps specified allow for access through the RS-232 (serial) port interface. Rated medium severity (CVSS 5.3), this vulnerability is no authentication required. No vendor patch available.
BD Totalys MultiProcessor, versions 1.70 and earlier, contain hardcoded credentials. Rated high severity (CVSS 7.8), this vulnerability is low attack complexity. No vendor patch available.
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. Rated medium severity (CVSS 5.7), this vulnerability is low attack complexity. No vendor patch available.
Specific BD Pyxis™ products were installed with default credentials and may presently still operate with these credentials. Rated high severity (CVSS 8.8), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
BD Alaris PC Unit, Model 8015, Versions 9.33.1 and earlier and BD Alaris Systems Manager, Versions 4.33 and earlier The affected products are vulnerable to a network session authentication. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
In BD Pyxis MedStation ES System v1.6.1 and Pyxis Anesthesia (PAS) ES System v1.6.1, a restricted desktop environment escape vulnerability exists in the kiosk mode functionality of affected devices. Rated medium severity (CVSS 6.1), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
In Pyxis ES Versions 1.3.4 through to 1.6.1 and Pyxis Enterprise Server, with Windows Server Versions 4.4 through 4.12, a vulnerability has been identified where existing access privileges are not. Rated high severity (CVSS 8.8), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.
BD Alaris Gateway versions, 1.0.13,1.1.3 Build 10,1.1.3 MR Build 11,1.1.5, and 1.1.6, The web browser user interface on the Alaris Gateway Workstation does not prevent an attacker with knowledge of. Rated medium severity (CVSS 5.3), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
BD Alaris Gateway Workstation Versions, 1.1.3 Build 10, 1.1.3 MR Build 11, 1.2 Build 15, 1.3.0 Build 14, 1.3.1 Build 13, This does not impact the latest firmware Versions 1.3.2 and 1.6.1,. Rated critical severity (CVSS 10.0), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
BD FACSLyric Research Use Only, Windows 10 Professional Operating System, U.S. Rated medium severity (CVSS 6.8), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication. Rated critical severity (CVSS 9.4), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
A vulnerability in ReadA version 1.1.0.2 and previous allows an authorized user with access to a privileged account on a BD Kiestra system (Kiestra TLA, Kiestra WCA, and InoqulA+ specimen processor). Rated medium severity (CVSS 6.3). No vendor patch available.
A vulnerability in DB Manager version 3.0.1.0 and previous and PerformA version 3.0.0.0 and previous allows an authorized user with access to a privileged account on a BD Kiestra system (Kiestra TLA,. Rated medium severity (CVSS 5.6). No vendor patch available.
A hard-coded password issue was discovered in Becton, Dickinson and Company (BD) PerformA, Version 2.0.14.0 and prior versions, and KLA Journal Service, Version 1.0.51 and prior versions. Rated critical severity (CVSS 9.8), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
An issue was discovered in Becton, Dickinson and Company (BD) Alaris 8015 Point of Care (PC) unit, Version 9.5 and prior versions, and Version 9.7. Rated medium severity (CVSS 5.3), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
An issue was discovered in Becton, Dickinson and Company (BD) Alaris 8015 Point of Care (PC) unit, Version 9.5 and prior versions, and Version 9.7, and 8000 PC unit. Rated medium severity (CVSS 4.9), this vulnerability is no authentication required. No vendor patch available.
The FACSChorus software does not properly assign data access privileges for operating system user accounts. Rated low severity (CVSS 3.5), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
The FACSChorus software database can be accessed directly with the privileges of the currently logged-in user. Rated medium severity (CVSS 4.3), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
The FACSChorus software contains sensitive information stored in plaintext. Rated medium severity (CVSS 4.3), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
The FACSChorus workstation does not prevent physical access to its PCI express (PCIe) slots, which could allow a threat actor to insert a PCI card designed for memory capture. Rated low severity (CVSS 2.4), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
The Operating System hosting the FACSChorus application is configured to allow transmission of hashed user credentials upon user action without adequately validating the identity of the requested. Rated low severity (CVSS 3.8), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
There is no BIOS password on the FACSChorus workstation. Rated medium severity (CVSS 5.2), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
The FACSChorus workstation operating system does not restrict what devices can interact with its USB ports. Rated medium severity (CVSS 5.7), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
An insecure connection between Systems Manager and CQI Reporter application could expose infusion data to an attacker. Rated low severity (CVSS 3.5), this vulnerability is low attack complexity. No vendor patch available.
Alaris Systems Manager does not perform input validation during the Device Import Function. Rated medium severity (CVSS 6.9), this vulnerability is low attack complexity. No vendor patch available.
A malicious file could be uploaded into a System Manager User Import Function resulting in a hijacked session. Rated high severity (CVSS 8.2), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
A GRE dataset file within Systems Manager can be tampered with and distributed to PCUs. Rated medium severity (CVSS 6.7), this vulnerability is low attack complexity. No vendor patch available.
The data flowing between the PCU and its modules is insecure. Rated medium severity (CVSS 6.1), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
The configuration from the PCU can be modified without authentication using physical connection to the PCU. Rated medium severity (CVSS 6.8), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
The firmware update package for the wireless card is not properly signed and can be modified. Rated medium severity (CVSS 5.7), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
The BD BodyGuard™ infusion pumps specified allow for access through the RS-232 (serial) port interface. Rated medium severity (CVSS 5.3), this vulnerability is no authentication required. No vendor patch available.
BD Totalys MultiProcessor, versions 1.70 and earlier, contain hardcoded credentials. Rated high severity (CVSS 7.8), this vulnerability is low attack complexity. No vendor patch available.
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. Rated medium severity (CVSS 5.7), this vulnerability is low attack complexity. No vendor patch available.
Specific BD Pyxis™ products were installed with default credentials and may presently still operate with these credentials. Rated high severity (CVSS 8.8), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
BD Alaris PC Unit, Model 8015, Versions 9.33.1 and earlier and BD Alaris Systems Manager, Versions 4.33 and earlier The affected products are vulnerable to a network session authentication. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
In BD Pyxis MedStation ES System v1.6.1 and Pyxis Anesthesia (PAS) ES System v1.6.1, a restricted desktop environment escape vulnerability exists in the kiosk mode functionality of affected devices. Rated medium severity (CVSS 6.1), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
In Pyxis ES Versions 1.3.4 through to 1.6.1 and Pyxis Enterprise Server, with Windows Server Versions 4.4 through 4.12, a vulnerability has been identified where existing access privileges are not. Rated high severity (CVSS 8.8), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.
BD Alaris Gateway versions, 1.0.13,1.1.3 Build 10,1.1.3 MR Build 11,1.1.5, and 1.1.6, The web browser user interface on the Alaris Gateway Workstation does not prevent an attacker with knowledge of. Rated medium severity (CVSS 5.3), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
BD Alaris Gateway Workstation Versions, 1.1.3 Build 10, 1.1.3 MR Build 11, 1.2 Build 15, 1.3.0 Build 14, 1.3.1 Build 13, This does not impact the latest firmware Versions 1.3.2 and 1.6.1,. Rated critical severity (CVSS 10.0), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
BD FACSLyric Research Use Only, Windows 10 Professional Operating System, U.S. Rated medium severity (CVSS 6.8), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication. Rated critical severity (CVSS 9.4), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
A vulnerability in ReadA version 1.1.0.2 and previous allows an authorized user with access to a privileged account on a BD Kiestra system (Kiestra TLA, Kiestra WCA, and InoqulA+ specimen processor). Rated medium severity (CVSS 6.3). No vendor patch available.
A vulnerability in DB Manager version 3.0.1.0 and previous and PerformA version 3.0.0.0 and previous allows an authorized user with access to a privileged account on a BD Kiestra system (Kiestra TLA,. Rated medium severity (CVSS 5.6). No vendor patch available.
A hard-coded password issue was discovered in Becton, Dickinson and Company (BD) PerformA, Version 2.0.14.0 and prior versions, and KLA Journal Service, Version 1.0.51 and prior versions. Rated critical severity (CVSS 9.8), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
An issue was discovered in Becton, Dickinson and Company (BD) Alaris 8015 Point of Care (PC) unit, Version 9.5 and prior versions, and Version 9.7. Rated medium severity (CVSS 5.3), this vulnerability is no authentication required, low attack complexity. No vendor patch available.
An issue was discovered in Becton, Dickinson and Company (BD) Alaris 8015 Point of Care (PC) unit, Version 9.5 and prior versions, and Version 9.7, and 8000 PC unit. Rated medium severity (CVSS 4.9), this vulnerability is no authentication required. No vendor patch available.